Listing 1 - 10 of 15 | << page >> |
Sort by
|
Choose an application
The adrenal gland plays essential roles in the control of body homeostasis, stress and immune responses. The adrenal cortex represents up to 90% of the gland and is specialised in the production of mineralocorticoids, glucocorticoids and adrenal androgens. This production is tightly coordinated and results from a unique zonal organisation. Although our knowledge of the molecular mechanisms controlling adrenal steroidogenesis is quite extensive, for decades, the mechanisms of adrenal cortex development, cellular homeostasis and renewal have remained elusive. The advent of new high-throughput technologies and sophisticated genetic approaches has brought tremendous progress in our understanding of how the adrenal cortex achieves and maintains its particular organisation. The aim of this Frontiers in Endocrinology Topic is to provide readers with a snapshot of our current knowledge on adrenal physiology and how deregulations of these processes result in adrenal diseases. This includes but is not limited to, basic research on adrenal development, cell lineage identification, progenitor cells, tissue renewal, control of differentiation and zonation and clinical research on the identification of disease-related genes.
Adrenal cortex --- Adrenal cortex. --- Diseases. --- development --- adrenal --- Disease --- Hyperplasia --- Insufficiency --- zonation --- Physiology --- Adenoma --- Cancer
Choose an application
This book presents an overview of adrenal tumors written by a multidisciplinary team of world experts who provide comprehensive, evidence-based perspective of their topics in this field and current approaches to the management of adrenal tumors. The areas discussed in this book include an overview of adrenal incidentalomas, unusual presentations of adrenal tumors, genetic basis of pheochromocytomas and paragangliomas, pathophysiology, and medical and surgical treatment and approaches to patients with benign and malignant adrenal tumors. Each chapter written by these experts provides clinical evidence, treatment recommendations, and algorithms. Clinical Management of Adrenal Tumors will serve as a valuable resource of current information regarding adrenal tumors for medical students, residents in training, physicians, and researchers.
Tumor antigens. --- Adrenal cortex. --- Adrenal glands --- Hypothalamic-pituitary-adrenal axis --- Antigens --- Tumor markers --- Medicine --- Neuroendocrinology --- Endocrinology --- Health Sciences
Choose an application
Corticosteroids are mainly used to reduce inflammation and suppress the immune system. Corticosteroids will only be prescribed if the potential benefits of treatment outweigh the risks. They will also be prescribed at the lowest effective dose for the shortest possible time. This book will strive to highlight the importance of corticosteroids, to focus on minimizing side effects, to monitor and sensitize the population on the potential adverse effects of misuse, to provide additional knowledge about the design and development of new drug delivery systems loaded with corticosteroids potentially useful in the treatment of chronic inflammatory-based diseases, and to reduce inflammation and affect the immune system. The major objective of this book will be to present the information in a lucid, condensed, and cohesive form and to specially cater to the needs of readers in medicine and pharmacy.
Adrenocortical hormones. --- Adrenal cortex hormones --- Adrenal steroids --- Adrenocorticoids --- Corticoids --- Corticosteroids --- Adrenal cortex --- Steroid hormones --- Medicine --- Endocrinology --- Health Sciences
Choose an application
By stimulating adrenal gland and corticosteroid synthesis, the adrenocorticotropic hormone (ACTH) plays a central role in response to stress. In this Research Topic, a particular attention has been given to the recent developments on adrenocortical zonation; the growth-promoting activities of ACTH; the various steps involved in acute and chronic regulation of steroid secretion by ACTH, including the effect of ACTH on circadian rhythms of glucocorticoid secretion. The Research Topic also reviews progress and challenges surrounding the properties of ACTH binding to the MC2 receptor (MC2R), including the importance of melanocortin-2 receptor accessory protein (MRAP) in MC2R expression and function, the various intracellular signaling cascades, which involve not only protein kinase A, the key mediator of ACTH action, but also phosphatases, phosphodiesterases, ion channels and the cytoskeleton. The importance of the proteins involved in the cell detoxification is also considered, in particular the effect that ACTH has on protection against reactive oxygen species generated during steroidogenesis. The impact of the cellular microenvironment, including local production of ACTH is discussed, both as an important factor in the maintenance of homeostasis, but also in pathological situations, such as severe inflammation. Finally, the Research Topic reviews the role that the pituitary-adrenal axis may have in the development of metabolic disorders. In addition to mutations or alterations of expression of genes encoding components of the steroidogenesis and signaling pathways, chronic stress and sleep disturbance are both associated with hyperactivity of the adrenal gland. A resulting effect is increased glucocorticoid secretion inducing food intake and weight gain, which, in turn, leads to insulin and leptin resistance. These aspects are described in detail in this Research Topic by key investigators in the field. Many of the aspects addressed in this Research Topic still represent a stimulus for future studies, their outcome aimed at providing evidence of the central position occupied by the adrenal cortex in many metabolic functions when its homeostasis is disrupted. An in-depth investigation of the mechanisms underlying these pathways will be invaluable in developing new therapeutic tools and strategies.
ACTH. --- Hypothalamic-pituitary-adrenal axis. --- Adrenal Cortex --- cortisol --- MC2R --- signaling --- corticosteroids --- proliferation --- adrenal tumors --- Cushing --- ACTH --- Aldosterone
Choose an application
Experiences during early life program the central nervous- and endocrine-systems with consequences for susceptibility to physical and mental disorders. These programming effects depend on genetic and epigenetic factors, and their outcome leads to an adaptive or maladaptive phenotype to a given later environmental context. This Research Topic focused on the hypothalamus-pituitary-adrenal (HPA)-axis and stress-related phenotypes, and on how HPA-axis programming by the environment precisely occurs. We included original research, mini-review and review papers on a broad range of topics related to HPA-axis programming.
Hypothalamic-pituitary-adrenal axis. --- HPA axis --- Vulnerability --- resilience --- early life stress --- materna
Choose an application
Stereotactic radiosurgery is a relatively recent radiation technique initially developed using a frame-based system in 1949 by a Swedish neurosurgeon, Lars Leksell, for lesions not amendable to surgical resection. Radiosurgery is founded on principles of extreme radiation dose escalation, afforded by precise dose delivery with millimeter accuracy. Building upon the success of frame-based radiosurgery techniques, which were limited to cranial tumors and invasive head-frame placement, advances in radiation delivery and image-guidance have lead to the development of stereotactic body radiotherapy (SBRT). SBRT allows for frameless delivery of dose distributions akin to frame-based cranial stereotactic radiosurgery to both cranial and extra-cranial sites and has emerged as a important treatment strategy for a variety of cancers from the cranium to prostate. Herein we highlight ongoing investigations for the clinical application of SBRT for a variety of primary and recurrence cancers aimed at examining the growing clinical evidence supporting emerging roles for SBRT in the ever growing oncologic armamentarium.
Stereotactic radiosurgery --- Gynecologic --- Central Nervous System --- Non small cell lung cancer --- head and neck --- stereotactic body radiation therapy --- Prostate --- Adrenal metastases
Choose an application
Circadian clocks are endogenous and temperature-compensating timekeepers that provide temporal organization of biological processes in living organisms. Circadian rhythms allow living organisms to adapt to the daily light cycles associated with Earth's rotation and to anticipate and prepare for precise and regular environmental changes. This book discusses the fundamental advances of how the circadian clock regulates critical biological functions as well as the cellular and molecular mechanisms controlling circadian rhythm in living organisms. It also provides new insights into and sheds new light on the current research trends and future research directions related to circadian rhythm. This book provokes interest in many readers, researchers and scientists, who can find this information useful for the advancement of their research works towards a better understanding of circadian rhythm regulatory mechanisms.
Pituitary gland--Diseases. --- Pituitary-adrenal function tests. --- Circadian rhythms. --- Behavior, Circadian --- Biological clocks, Daily --- Circadian behavior --- Circadian clocks --- Circadian cycles --- Clocks, Circadian --- Cycles, Circadian --- Daily activity cycles --- Daily biological clocks --- Diel cycles --- Diurnal rhythms --- Rhythms, Circadian --- Biological rhythms --- Adrenal-pituitary function tests --- Endocrine function tests --- Pituitary gland --- Diseases. --- Life Sciences --- Neuroscience
Choose an application
Major technological advances in genomics have made it possible to identify critical genetic alterations in cancer, rendering oncology well along the path to “personalised cancer medicine”. Thanks to developments in genetics, several mutations and gene rearrangements have been identified in patients with endocrine cancers (e.g., thyroid and adrenocortical carcinoma). In particular, each patient can be considered as a unique, individual one, with unique genetic information. The aim of this Special Issue is to offer an overview of exciting new research in the area of endocrine tumours may set the stage for an innovative personalised management and precision medicine modalities for individualised care.New affordable individual genomic analyses, as well as the opportunity to test new compounds in primary cells may allow a personalised management of patients with endocrine malignancies. This approach may improve the prediction of clinical outcome and therapeutic effectiveness, as well as help to avoid the use of ineffective drugs. However, further efforts are needed to obtain an adjustment of clinical management in patients with endocrine cancers that would rely solely or in great part on genetic information. This Special Issue includes basic, translational, and clinical papers on personalised medicine in endocrine malignancies (i.e., thyroid and adrenal), especially focusing on diagnostic and prognostic biomarkers, as well as novel drug targets or targeted treatments, including eventual clinical trials.
papillary thyroid cancer --- SUV PET/CT --- BRAF V600E --- immune checkpoint inhibitors (ICIs) --- ipilimumab --- nivolumab --- prolactinoma --- Cushing’s disease --- aggressive pituitary tumor --- aggressive PitNET --- aggressive pituitary adenoma --- pituitary carcinoma --- adrenocortical cancer --- adrenal adenomas --- adrenal tumors --- p53 --- p27 --- ki-67 --- reticulin --- mitotane --- adjuvant treatment --- recurrence --- recurrence free survival --- timing --- intratumoral heterogeneity --- thyroid tumor --- BRAF --- RET/PTC rearrangements --- RAS mutation --- adrenal cortex --- carcinoma --- angiogenesis --- gene expression --- osteopontin --- hyaluronan synthase 1 --- multikinase inhibitors --- sorafenib --- lenvatinib --- differentiated thyroid cancer --- radioiodine resistance --- predictive marker --- predictors --- response to treatment --- survival --- information needs and preferences --- focus group interview --- personalized medicine --- neuroendocrine tumours --- phaeochromocytoma --- paraganglioma --- molecular clusters --- n/a --- Cushing's disease
Choose an application
Immunotherapy has become a viable treatment modality for a variety of cancers (and referred to as Science Magazine’s “Breakthrough of the Year” in 2013, as well as ASCO’s “Advance of the Year” in both 2016 and 2017). This Special Issue is focused on the relevance of immunobiology in brain tumors, touching on elements of immune suppression, immune stimulation, and the immune microenvironment, with culminations in translational immunotherapy.
vaccine therapy --- oncoantigen --- tumor associate antigen --- tumor angiogenesis --- high-grade glioma --- pituitary neuroendocrine tumors --- VEGF --- Treg --- TAM --- PD-1 --- PD-L1 --- tumor microenvironment (TME) --- glioblastoma multiforme (GBM) --- GBM-associated macrophages (GAMs) --- exosomes --- oncomiR-21 --- STAT3 inhibitor --- glioma --- diffusion tensor imaging --- generalized q-ball imaging --- treatment-related effects --- multiple resections --- adrenal insufficiency --- Addison’s disease --- bevacizumab --- cerebral radiation necrosis --- craniopharyngioma --- inflammation --- checkpoint inhibitors --- Interleukin-6
Choose an application
Growing evidence shows that a dietary pattern inspired by Mediterranean dietprinciples is associated with numerous health benefits. A Mediterranean-typediet has been demonstrated to exert a preventive effect toward cardiovasculardiseases, in both Mediterranean and non-Mediterranean populations. Part ofthese properties may depend on a positive action toward healthier metabolism,decreasing the risk of diabetes and metabolic-syndrome-related conditions.Some studies also suggested a potential role in preventing certain cancers. Finally,newer research has showed that a higher adherence to the Mediterranean diet isassociated with a lower risk of cognitive decline, depression, and other mentaldisorders. Overall, a better understanding of the key elements of this dietarypattern, the underlying mechanisms, and targets, are needed to corroboratecurrent evidence and provide insights on new and potential outcomes.ThisSpecial Issue welcomes original research and reviews of literature concerningthe Mediterranean diet and various health outcomes:Observational studies onestablished nutritional cohorts (preferred), case-control studies, or populationsample on the association with non-communicable diseases;Level of evidenceon the association with human health, including systematic reviews and metaanalyses;Evaluation of application of Mediterranean diet principles in non-Mediterranean countries;Description of mechanisms of action, pathways, andtargets at the molecular level, including interaction with gut microbiota.
offspring --- dietary intervention study --- n/a --- mental health --- noncommunicable diseases --- plasma lipids --- depressive symptoms --- children --- metabolomics --- Mediterranean Diet --- immune system --- olive oil --- healthy lifestyle --- obesity --- prevention --- telomere length --- risk factors --- Mediterranean diet --- adolescents --- pregnancy --- athletes --- dietary change --- microbiome --- nutrition --- nuts --- whole-grain --- health communication --- childbearing age --- dementia --- Italy --- quality of life --- wine --- dietary intervention --- questionnaire --- non-alcoholic fatty liver disease --- public health policy --- relative Mediterranean diet score --- DNA damage --- fruit --- food groups --- cohort --- cognitive decline --- vegetable --- DNA repair --- university students --- epidemiology --- Mediterranean diet pyramid --- dietary intake --- motivational climate --- weight status --- glucose control --- diet --- cardiovascular risk --- resveratrol --- sleep quality --- BMI --- cardiovascular disease --- catechins --- sports --- socioeconomic factors --- self-concept --- child health --- hypothalamic–pituitary–adrenal-HPA axis --- physical activity --- Spain --- barriers --- diet quality --- fish --- childhood obesity --- translation --- diabetes --- dairy --- hypothalamic-pituitary-adrenal-HPA axis
Listing 1 - 10 of 15 | << page >> |
Sort by
|